Drug LitigationCelexa Linked to Infant Withdrawal Syndrome

December 14, 2011

According to James L. Mills, MD, chief of pediatric epidemiology at the U.S. National Institute of Child Health and Human Development, commonly prescribed antidepressants, known as selective serotonin reuptake inhibitors (SSRIs), cause infant withdrawal syndrome (IWS) in an estimated 30 percent of newborns exposed to SSRIs while developing in the womb. Celexa (citalopram) is just one of several SSRIs. If you’ve taken Celexa (citalopram) during your pregnancy, you may have inadvertently put your child at risk of developing IWS.

 

IWS, also known as neonatal withdrawal or neonatal abstinence syndrome (NAS), occurs when a child is exposed to – and, in some measure, becomes chemically dependent upon – an opiate, such as alcohol or SSRIs. Tragically, many pregnant patients don’t realize that their SSRI prescription might cause IWS/NAS – or what its long-term effects might be.

 

Nachawati Law Group protects children, mothers, and families adversely affected by SSRIs like Celexa (citalopram). If you or your loved one has been injured by an SSRI prescription, you should contact the dangerous drug experts at Nachawati Law Group. With years of experience and dedicated expertise, we’re prepared to fight for you.  

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.